Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: A prospective randomised multicentre trial

Citation
S. Post et al., Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: A prospective randomised multicentre trial, EUR J VAS E, 22(3), 2001, pp. 226-231
Citations number
24
Categorie Soggetti
Surgery
Journal title
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
ISSN journal
10785884 → ACNP
Volume
22
Issue
3
Year of publication
2001
Pages
226 - 231
Database
ISI
SICI code
1078-5884(200109)22:3<226:DVPGFF>2.0.ZU;2-J
Abstract
Objectives: to compare the patency of PTFE (Polytetrafluoroethylene) and un sealed knitted Dacron femoro-popliteal bypasses. Design: multi-centre prosp ective randomised trial. Materials and methods; of 203 patients randomised, 194 were included in the final analysis (103 Dacron grafts and 91 PTFE grafts). The median follow-u p was 36 Months (range: 6-72 months); the distal anastomosis was above-knee in 141 and below-knee in 53 cases. Univariate comparisons of patency were made by the Kaplan-Meier method, multi-variate calculations on the effects of covariables by a Cox regression analysis. Results: there was no difference regarding primary and secondary patency or limb salvage between Dacron and PTFE. The primary 3-year patency for Dacro n grafts was 64% (95% confidence interval [CI] 55-74%) and for PTFE grafts 61% (C.I. 49-72%). The corresponding 3-year secondary patency was 81% (C.I. 73-89%) and 75% (C.I. 65-86%) respectively, the limb salvage rate 90% (C.I . 84-96%) and 91% (C.I. 84-97%). Upon multivariateanalysis below-knee anast omosis was the principal independent predictor of printary graft failzire ( risk ratio 1.7 [C.I. 1.05-2.81), iinpaired secondary patency was associated with infragenicular bypass (risk ratio 3.3 [C.I. 1.8-6.3]) and distal gang rene (risk ratio [C.I. 1.01-3.81 p = 0.048), major amputation was independe ntly predicted by below-knee bypass, tissue necrosis, and poor run-off inde x. Conclusions: PTFE and Dacron are equally suitable for femoro-popliteal bypa ss.